Literature DB >> 26274541

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium.

Sung Wook Park1, Jin Hyoung Kim2, Woo Jin Park3, Jeong Hun Kim4.   

Abstract

The eye is a small and enclosed organ which makes it an ideal target for gene therapy. Recently various strategies have been applied to gene therapy in retinopathies using non-viral and viral gene delivery to the retina and retinal pigment epithelium (RPE). Subretinal injection is the best approach to deliver viral vectors directly to RPE cells. Before the clinical trial of a gene therapy, it is inevitable to validate the efficacy of the therapy in animal models of various retinopathies. Thus, subretinal injection in mice becomes a fundamental technique for an ocular gene therapy. In this protocol, we provide the easy and replicable technique for subretinal injection of viral vectors to experimental mice. This technique is modified from the intravitreal injection, which is widely used technique in ophthalmology clinics. The representative results of RPE/choroid/scleral complex flat-mount will help to understand the efficacy of this technique and adjust the volume and titer of viral vectors for the extent of gene transduction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26274541      PMCID: PMC4544934          DOI: 10.3791/53030

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  20 in total

1.  Intraocular delivery of recombinant virus.

Authors:  F Q Liang; V Anand; A M Maguire; J Bennett
Journal:  Methods Mol Med       Date:  2001

Review 2.  Gene transfer for neovascular age-related macular degeneration.

Authors:  Peter A Campochiaro
Journal:  Hum Gene Ther       Date:  2011-05       Impact factor: 5.695

3.  Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.

Authors:  G Le Meur; K Stieger; A J Smith; M Weber; J Y Deschamps; D Nivard; A Mendes-Madeira; N Provost; Y Péréon; Y Cherel; R R Ali; C Hamel; P Moullier; F Rolling
Journal:  Gene Ther       Date:  2006-10-05       Impact factor: 5.250

4.  Sustained transduction of ocular cells with a bovine immunodeficiency viral vector.

Authors:  Kyoichi Takahashi; Tianci Luo; Yoshitsugu Saishin; Yumiko Saishin; Jennifer Sung; Sean Hackett; R K Brazzell; Michael Kaleko; Peter A Campochiaro
Journal:  Hum Gene Ther       Date:  2002-07-20       Impact factor: 5.695

5.  Subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye.

Authors:  Katherine J Wert; Jessica M Skeie; Richard J Davis; Stephen H Tsang; Vinit B Mahajan
Journal:  J Vis Exp       Date:  2012-11-25       Impact factor: 1.355

6.  Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.

Authors:  Thomas J Conlon; Wen-Tao Deng; Kirsten Erger; Travis Cossette; Ji-jing Pang; Renee Ryals; Nathalie Clément; Brian Cleaver; Issam McDoom; Shannon E Boye; Marc C Peden; Mark B Sherwood; Corinne R Abernathy; Fowzan S Alkuraya; Sanford L Boye; William W Hauswirth
Journal:  Hum Gene Ther Clin Dev       Date:  2013-04-03       Impact factor: 5.032

7.  Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice.

Authors:  Sung Wook Park; Jin Hyoung Kim; Inhee Mook-Jung; Kyu-Won Kim; Woo Jin Park; Kyu Hyung Park; Jeong Hun Kim
Journal:  Neurobiol Aging       Date:  2014-03-15       Impact factor: 4.673

8.  Retinal detachment model in rodents by subretinal injection of sodium hyaluronate.

Authors:  Hidetaka Matsumoto; Joan W Miller; Demetrios G Vavvas
Journal:  J Vis Exp       Date:  2013-09-11       Impact factor: 1.355

9.  Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.

Authors:  Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

10.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

Authors:  Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra
Journal:  Lancet       Date:  2014-01-16       Impact factor: 79.321

View more
  9 in total

1.  Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research.

Authors:  Mark C Butler; Jack M Sullivan
Journal:  J Vis Exp       Date:  2018-11-02       Impact factor: 1.355

2.  Transpupillary Two-photon In vivo Imaging of the Mouse Retina.

Authors:  Zelun Wang; Sean McCracken; Philip R Williams
Journal:  J Vis Exp       Date:  2021-02-13       Impact factor: 1.424

3.  Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.

Authors:  Kyoungmi Kim; Sung Wook Park; Jin Hyoung Kim; Seung Hwan Lee; Daesik Kim; Taeyoung Koo; Kwang-Eun Kim; Jeong Hun Kim; Jin-Soo Kim
Journal:  Genome Res       Date:  2017-02-16       Impact factor: 9.043

4.  Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection.

Authors:  Sarah J Wassmer; Livia S Carvalho; Bence György; Luk H Vandenberghe; Casey A Maguire
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

5.  Trans-ocular Electric Current In Vivo Enhances AAV-Mediated Retinal Gene Transduction after Intravitreal Vector Administration.

Authors:  Hongman Song; Ronald A Bush; Yong Zeng; Haohua Qian; Zhijian Wu; Paul A Sieving
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-21       Impact factor: 6.698

6.  CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis.

Authors:  Dong Hyun Jo; Dong Woo Song; Chang Sik Cho; Un Gi Kim; Kyu Jun Lee; Kihwang Lee; Sung Wook Park; Daesik Kim; Jin Hyoung Kim; Jin-Soo Kim; Seokjoong Kim; Jeong Hun Kim; Jung Min Lee
Journal:  Sci Adv       Date:  2019-10-30       Impact factor: 14.136

7.  High-purity production and precise editing of DNA base editing ribonucleoproteins.

Authors:  Hyeon-Ki Jang; Dong Hyun Jo; Seu-Na Lee; Chang Sik Cho; You Kyeong Jeong; Youngri Jung; Jihyeon Yu; Jeong Hun Kim; Jae-Sung Woo; Sangsu Bae
Journal:  Sci Adv       Date:  2021-08-27       Impact factor: 14.136

8.  Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration.

Authors:  Un Chul Park; Susanna S Park; Bo Hee Kim; Sung Wook Park; Young Joo Kim; Whitney Cary; Johnathon D Anderson; Jan A Nolta; Hyeong Gon Yu
Journal:  Ann Transl Med       Date:  2021-08

Review 9.  Subretinal Injection Techniques for Retinal Disease: A Review.

Authors:  Cristina Irigoyen; Asier Amenabar Alonso; Jorge Sanchez-Molina; María Rodríguez-Hidalgo; Araceli Lara-López; Javier Ruiz-Ederra
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.